{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:13:48Z","timestamp":1750220028059,"version":"3.41.0"},"publisher-location":"New York, NY, USA","reference-count":35,"publisher":"ACM","license":[{"start":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T00:00:00Z","timestamp":1663459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.acm.org\/publications\/policies\/copyright_policy#Background"}],"content-domain":{"domain":["dl.acm.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,18]]},"DOI":"10.1145\/3569192.3569203","type":"proceedings-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T13:55:03Z","timestamp":1674827703000},"page":"61-66","update-policy":"https:\/\/doi.org\/10.1145\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["In Silico Drug Repurposing using Knowledge Graph Embeddings for Alzheimer's Disease"],"prefix":"10.1145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9814-3119","authenticated-orcid":false,"given":"Geesa","family":"Daluwatumulle","sequence":"first","affiliation":[{"name":"University of Colombo School of Computing, Sri Lanka"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8915-7829","authenticated-orcid":false,"given":"Rupika","family":"Wijesinghe","sequence":"additional","affiliation":[{"name":"University of Colombo School of Computing, Sri Lanka"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1392-7791","authenticated-orcid":false,"given":"Ruvan","family":"Weerasinghe","sequence":"additional","affiliation":[{"name":"University of Colombo School of Computing, Sri Lanka"}]}],"member":"320","published-online":{"date-parts":[[2023,1,27]]},"reference":[{"key":"e_1_3_2_2_1_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.09.018"},{"key":"e_1_3_2_2_2_1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1017\/S0031182017000993","article-title":"Repurposing as a strategy for the discovery of new anti-leishmanials","volume":"145","author":"Denny Paul W.","year":"2018","unstructured":"Paul W. Denny Rebecca L. Charlton , Bartira Rossi-Bergmann and Patrick G. Steel . 2018 . Repurposing as a strategy for the discovery of new anti-leishmanials : The-state-of-the-art. Parasitology 145 (2018), 219 \u2013 236 . https:\/\/doi.org\/10.1017\/S0031182017000993 10.1017\/S0031182017000993 Paul W. Denny Rebecca L. Charlton, Bartira Rossi-Bergmann and Patrick G. Steel. 2018. Repurposing as a strategy for the discovery of new anti-leishmanials: The-state-of-the-art. Parasitology 145 (2018), 219\u2013236. https:\/\/doi.org\/10.1017\/S0031182017000993","journal-title":"The-state-of-the-art. Parasitology"},{"key":"e_1_3_2_2_3_1","volume-title":"Approves Alzheimer's Drug Despite Fierce Debate Over Whether It Works - The New York Times. Retrieved","author":"Belluck Pam","year":"2021","unstructured":"Pam Belluck and Rebecca Robbins . 2021. F.D. A. Approves Alzheimer's Drug Despite Fierce Debate Over Whether It Works - The New York Times. Retrieved September 2, 2021 from https:\/\/www.nytimes.com\/2021\/06\/07\/health\/aduhelm-fda-alzheimers-drug.html.html Pam Belluck and Rebecca Robbins. 2021. F.D.A. Approves Alzheimer's Drug Despite Fierce Debate Over Whether It Works - The New York Times. Retrieved September 2, 2021 from https:\/\/www.nytimes.com\/2021\/06\/07\/health\/aduhelm-fda-alzheimers-drug.html.html"},{"key":"e_1_3_2_2_4_1","volume-title":"Mol. Asp. Ther. Appl.","author":"Rudrapal Mithun","year":"2020","unstructured":"Mithun Rudrapal , Shubham J. Khairnar , and Anil G. Jadhav , \u201cDrug Repurposing (DR): An Emerging Approach in Drug Discovery,\u201d Drug Repurposing - Hypothesis , Mol. Asp. Ther. Appl. , Jul. 2020 , doi: 10.5772\/INTECHOPEN.93193. 10.5772\/INTECHOPEN.93193 Mithun Rudrapal, Shubham J. Khairnar, and Anil G. Jadhav, \u201cDrug Repurposing (DR): An Emerging Approach in Drug Discovery,\u201d Drug Repurposing - Hypothesis, Mol. Asp. Ther. Appl., Jul. 2020, doi: 10.5772\/INTECHOPEN.93193."},{"key":"e_1_3_2_2_5_1","doi-asserted-by":"publisher","DOI":"10.1109\/ACCESS.2018.2886311"},{"key":"e_1_3_2_2_6_1","first-page":"73","volume-title":"Mach. Learn. Res.","volume":"21","author":"Kazemi Seyed Mehran","year":"2020","unstructured":"Seyed Mehran Kazemi , Rishab Goel , Kshitij Jain , Ivan Kobyzev , Akshay Sethi , Peter Forsyth and Pascal Poupart , \u201c Representation learning for dynamic graphs: A survey,\u201d J . Mach. Learn. Res. , vol. 21 , pp. 1\u2013 73 , 2020 . Seyed Mehran Kazemi, Rishab Goel, Kshitij Jain, Ivan Kobyzev, Akshay Sethi, Peter Forsyth and Pascal Poupart, \u201cRepresentation learning for dynamic graphs: A survey,\u201d J. Mach. Learn. Res., vol. 21, pp. 1\u201373, 2020."},{"key":"e_1_3_2_2_7_1","volume-title":"SS symmetry A Survey on Knowledge Graph Embeddings for Link Prediction","author":"Wang Meihong","year":"2021","unstructured":"Meihong Wang , Linling Qiu , and Xialo Wang , \u201c SS symmetry A Survey on Knowledge Graph Embeddings for Link Prediction ,\u201d 2021 . Meihong Wang, Linling Qiu, and Xialo Wang, \u201cSS symmetry A Survey on Knowledge Graph Embeddings for Link Prediction,\u201d 2021."},{"key":"e_1_3_2_2_8_1","volume-title":"Getting to Know Your Data","author":"Han Jiawei","year":"2012","unstructured":"Jiawei Han , M. Kamber , and J. Pei , Getting to Know Your Data . 2012 . Jiawei Han, M. Kamber, and J. Pei, Getting to Know Your Data. 2012."},{"key":"e_1_3_2_2_9_1","first-page":"1","article-title":"A review of computational drug repositioning: Strategies, approaches, opportunities, challenges, and directions","volume":"12","author":"Rokne Jon G.","year":"2020","unstructured":"Jon G. Rokne Tamer N. Jarada and Reda Alhajj . 2020 . A review of computational drug repositioning: Strategies, approaches, opportunities, challenges, and directions . Journal of Cheminformatics 12 (2020), 1 \u2013 23 . https:\/\/doi.org\/10.1186\/s13321-020-00450-7 10.1186\/s13321-020-00450-7 Jon G. Rokne Tamer N. Jarada and Reda Alhajj. 2020. A review of computational drug repositioning: Strategies, approaches, opportunities, challenges, and directions. Journal of Cheminformatics 12 (2020), 1\u201323. https:\/\/doi.org\/10.1186\/s13321-020-00450-7","journal-title":"Journal of Cheminformatics"},{"key":"e_1_3_2_2_10_1","volume-title":"Petar Todorov, Kyle Evans Sarah A. Boswell, Nathan T. Johnson George Zhou, Peter K. Sorger Bradley T. Hyman, Mark W. Albers, and Artem Sokolov.","author":"Rodriguez Steve","year":"2021","unstructured":"Steve Rodriguez , Nienke Moret Clemens Hug , Petar Todorov, Kyle Evans Sarah A. Boswell, Nathan T. Johnson George Zhou, Peter K. Sorger Bradley T. Hyman, Mark W. Albers, and Artem Sokolov. 2021 . Machine learning identifies candidates for drug repurposing in Alzheimer's disease. Nature Communications 12 (2021). https:\/\/doi.org\/10.1038\/s41467-021-21330-0 10.1038\/s41467-021-21330-0 Steve Rodriguez, Nienke Moret Clemens Hug, Petar Todorov, Kyle Evans Sarah A. Boswell, Nathan T. Johnson George Zhou, Peter K. Sorger Bradley T. Hyman, Mark W. Albers, and Artem Sokolov. 2021. Machine learning identifies candidates for drug repurposing in Alzheimer's disease. Nature Communications 12 (2021). https:\/\/doi.org\/10.1038\/s41467-021-21330-0"},{"key":"e_1_3_2_2_11_1","doi-asserted-by":"publisher","DOI":"10.1109\/JBHI.2018.2856535"},{"key":"e_1_3_2_2_12_1","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1093\/bioinformatics\/btz156","article-title":"A new computational drug repurposing method using established disease-drug pair knowledge","volume":"35","author":"Saberian Nafiseh","year":"2019","unstructured":"Nafiseh Saberian , Michele Donato Azam Peyvandipour , Sahar Ansari , and Sorin Draghici . 2019 . A new computational drug repurposing method using established disease-drug pair knowledge . Bioinformatics 35 (2019), 3672 \u2013 3678 . https:\/\/doi.org\/10.1093\/bioinformatics\/btz156 10.1093\/bioinformatics Nafiseh Saberian, Michele Donato Azam Peyvandipour, Sahar Ansari, and Sorin Draghici. 2019. A new computational drug repurposing method using established disease-drug pair knowledge. Bioinformatics 35 (2019), 3672\u20133678. https:\/\/doi.org\/10.1093\/bioinformatics\/btz156","journal-title":"Bioinformatics"},{"key":"e_1_3_2_2_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btz418"},{"key":"e_1_3_2_2_14_1","volume-title":"Lei Xie Peter J. Tonge, and Philip E. Bourne.","author":"Kinnings Sarah L.","year":"2009","unstructured":"Sarah L. Kinnings , Nancy Buchmeier Nina Liu , Lei Xie Peter J. Tonge, and Philip E. Bourne. 2009 . Drug discovery using chemical systems biology: Repositioning the safe medicine Comtan to treat multi-drug and extensively drug resistant tuberculosis. PLoS Computational Biology 5 (2009). https:\/\/doi.org\/10.1371\/journal.pcbi.1000423 10.1371\/journal.pcbi.1000423 Sarah L. Kinnings, Nancy Buchmeier Nina Liu, Lei Xie Peter J. Tonge, and Philip E. Bourne. 2009. Drug discovery using chemical systems biology: Repositioning the safe medicine Comtan to treat multi-drug and extensively drug resistant tuberculosis. PLoS Computational Biology 5 (2009). https:\/\/doi.org\/10.1371\/journal.pcbi.1000423"},{"key":"e_1_3_2_2_15_1","first-page":"1","article-title":"Computational drug repositioning through heterogeneous network clustering","volume":"7","author":"Aronow ChaoWu Bruce J","year":"2013","unstructured":"Bruce J Aronow ChaoWu , Ranga C Gudivada and Anil G Jegga . 2013 . Computational drug repositioning through heterogeneous network clustering . BMC Systems Biology 7 (2013), 1 \u2013 9 . https:\/\/doi.org\/10.1186\/1752-0509-7-S5-S6 10.1186\/1752-0509-7-S5-S6 Bruce J Aronow ChaoWu, Ranga C Gudivada and Anil G Jegga. 2013. Computational drug repositioning through heterogeneous network clustering. BMC Systems Biology 7 (2013), 1\u20139. https:\/\/doi.org\/10.1186\/1752-0509-7-S5-S6","journal-title":"BMC Systems Biology"},{"key":"e_1_3_2_2_16_1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1108\/LHT-08-2019-0170","article-title":"Drug repurposing against Parkinson's disease by text mining the scientific literature","volume":"38","author":"Yongjun Zhu Fei Wang","year":"2020","unstructured":"Fei Wang Yongjun Zhu , Woojin Jung and Chao Che . 2020 . Drug repurposing against Parkinson's disease by text mining the scientific literature . Library Hi Tech 38 (2020), 741 \u2013 750 . https:\/\/doi.org\/10.1108\/LHT-08-2019-0170 10.1108\/LHT-08-2019-0170 Fei Wang Yongjun Zhu, Woojin Jung and Chao Che. 2020. Drug repurposing against Parkinson's disease by text mining the scientific literature. Library Hi Tech 38 (2020), 741\u2013750. https:\/\/doi.org\/10.1108\/LHT-08-2019-0170","journal-title":"Library Hi Tech"},{"key":"e_1_3_2_2_17_1","first-page":"1","article-title":"Drug repurposing for Parkinson's disease by integrating knowledge graph completion model and knowledge fusion of medical literature","volume":"13","author":"Zhang Xiaolin","year":"2021","unstructured":"Xiaolin Zhang and Chao Che . 2021 . Drug repurposing for Parkinson's disease by integrating knowledge graph completion model and knowledge fusion of medical literature . Future Internet 13 (2021), 1 \u2013 13 . https:\/\/doi.org\/10.3390\/fi13010014 10.3390\/fi13010014 Xiaolin Zhang and Chao Che. 2021. Drug repurposing for Parkinson's disease by integrating knowledge graph completion model and knowledge fusion of medical literature. Future Internet 13 (2021), 1\u201313. https:\/\/doi.org\/10.3390\/fi13010014","journal-title":"Future Internet"},{"key":"e_1_3_2_2_18_1","volume-title":"Building disease-specific drug-protein connectivity maps from molecular interaction networks and PubMed abstracts. PLoS Computational Biology 5","author":"Jiao Li Xiaoyan Zhu","year":"2009","unstructured":"Xiaoyan Zhu Jiao Li and Jake Yue Chen . 2009. Building disease-specific drug-protein connectivity maps from molecular interaction networks and PubMed abstracts. PLoS Computational Biology 5 ( 2009 ). https:\/\/doi.org\/10.1371\/journal.pcbi.1000450 10.1371\/journal.pcbi.1000450 Xiaoyan Zhu Jiao Li and Jake Yue Chen. 2009. Building disease-specific drug-protein connectivity maps from molecular interaction networks and PubMed abstracts. PLoS Computational Biology 5 (2009). https:\/\/doi.org\/10.1371\/journal.pcbi.1000450"},{"key":"e_1_3_2_2_19_1","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1177\/1460458220937101","article-title":"Knowledge-driven drug repurposing using a comprehensive drug knowledge graph","volume":"26","author":"Zhu Yongjun","year":"2020","unstructured":"Yongjun Zhu , Bo Jin Chao Che , Chang Su Ningrui Zhang , and Fei Wang . 2020 . Knowledge-driven drug repurposing using a comprehensive drug knowledge graph . Health Informatics Journal 26 (2020), 2737 \u2013 2750 . https:\/\/doi.org\/10.1177\/1460458220937101 10.1177\/1460458220937101 Yongjun Zhu, Bo Jin Chao Che, Chang Su Ningrui Zhang, and Fei Wang. 2020. Knowledge-driven drug repurposing using a comprehensive drug knowledge graph. Health Informatics Journal 26 (2020), 2737\u20132750. https:\/\/doi.org\/10.1177\/1460458220937101","journal-title":"Health Informatics Journal"},{"volume-title":"BMC Bioinformatics","author":"Kilicoglu Halil","key":"e_1_3_2_2_20_1","unstructured":"Halil Kilicoglu , Graciela Rosemblat , Marcelo Fiszman , and Dongwook Shin , \u201c Broad-coverage biomedical relation extraction with SemRep ,\u201d BMC Bioinformatics , vol. 21 , no. 1, pp. 1\u201328, 2020, doi: 10.1186\/s12859-020-3517-7. 10.1186\/s12859-020-3517-7 Halil Kilicoglu, Graciela Rosemblat, Marcelo Fiszman, and Dongwook Shin, \u201cBroad-coverage biomedical relation extraction with SemRep,\u201d BMC Bioinformatics, vol. 21, no. 1, pp. 1\u201328, 2020, doi: 10.1186\/s12859-020-3517-7."},{"volume-title":"PubMed","year":"2021","key":"e_1_3_2_2_21_1","unstructured":"\u201c PubMed .\u201d https:\/\/pubmed.ncbi.nlm.nih.gov\/ (accessed Oct. 02, 2021 ). \u201cPubMed.\u201d https:\/\/pubmed.ncbi.nlm.nih.gov\/ (accessed Oct. 02, 2021)."},{"key":"e_1_3_2_2_22_1","volume-title":"Biomed. Inform.","volume":"115","author":"Zhang Rui","year":"2021","unstructured":"Rui Zhang , Dimitar Hristovski , Dalton Schutte , Andrej Kastrin , Marcelo Fiszman , and Halil Kilicoglu , \u201c Drug repurposing for COVID-19 via knowledge graph completion,\u201d J . Biomed. Inform. , vol. 115 , 2021 , doi: 10.1016\/j.jbi.2021.103696 10.1016\/j.jbi.2021.103696 Rui Zhang, Dimitar Hristovski, Dalton Schutte, Andrej Kastrin, Marcelo Fiszman, and Halil Kilicoglu, \u201cDrug repurposing for COVID-19 via knowledge graph completion,\u201d J. Biomed. Inform., vol. 115, 2021, doi: 10.1016\/j.jbi.2021.103696"},{"volume-title":"Therapeutic Target Database (TTD)","year":"2022","key":"e_1_3_2_2_23_1","unstructured":"\u201c Therapeutic Target Database (TTD) .\u201d http:\/\/db.idrblab.net\/ttd\/ (accessed Mar. 24, 2022 ). \u201cTherapeutic Target Database (TTD).\u201d http:\/\/db.idrblab.net\/ttd\/ (accessed Mar. 24, 2022)."},{"volume-title":"Retrieved","year":"2022","key":"e_1_3_2_2_24_1","unstructured":"Ampligraph. 2022 . Bibliography \u2014 AmpliGraph 1.4.0 documentation . Retrieved March 27, 2022 from https:\/\/docs.ampligraph.org\/en\/1.4.0\/biblio.html Ampligraph. 2022. Bibliography \u2014 AmpliGraph 1.4.0 documentation. Retrieved March 27, 2022 from https:\/\/docs.ampligraph.org\/en\/1.4.0\/biblio.html"},{"volume-title":"Dement. Geriatr. Cogn. Disord.","author":"Urakami","key":"e_1_3_2_2_25_1","unstructured":"Urakami K., Takahashi K., Adachi Y., Matsushima E., Sano K., and Saito H. , \u201c Effects of indeloxazine administration on neurotransmitters in the cerebrospinal fluid of patients with dementia of Alzheimer type ,\u201d Dement. Geriatr. Cogn. Disord. , vol. 1 , no. 5, pp. 267\u2013271, 1990, doi: 10.1159\/000107151 10.1159\/000107151 Urakami K., Takahashi K., Adachi Y., Matsushima E., Sano K., and Saito H., \u201cEffects of indeloxazine administration on neurotransmitters in the cerebrospinal fluid of patients with dementia of Alzheimer type,\u201d Dement. Geriatr. Cogn. Disord., vol. 1, no. 5, pp. 267\u2013271, 1990, doi: 10.1159\/000107151"},{"volume-title":"Biology (Basel).","author":"Abate Giulia","key":"e_1_3_2_2_26_1","unstructured":"Giulia Abate , Daniela Uberti , and Simone Tambaro , \u201c Potential and Limits of Cannabinoids in Alzheimer's Disease Therapy ,\u201d Biology (Basel). , vol. 10 , no. 6, Jun. 2021, doi: 10.3390\/BIOLOGY10060542 10.3390\/BIOLOGY10060542 Giulia Abate, Daniela Uberti, and Simone Tambaro, \u201cPotential and Limits of Cannabinoids in Alzheimer's Disease Therapy,\u201d Biology (Basel)., vol. 10, no. 6, Jun. 2021, doi: 10.3390\/BIOLOGY10060542"},{"volume-title":"Pharmacopsychiatry","author":"Weyer","key":"e_1_3_2_2_27_1","unstructured":"Weyer G., Eul A., Milde K., Wierich W., and Herrmann W. M. , \u201c Cyclandelate in the treatment of patients with mild to moderate primary degenerative dementia of the Alzheimer type or vascular dementia: experience from a placebo controlled multi-center study ,\u201d Pharmacopsychiatry , vol. 33 , no. 3, pp. 89\u201397, 2000, doi: 10.1055\/S-2000-7978 10.1055\/S-2000-7978 Weyer G., Eul A., Milde K., Wierich W., and Herrmann W. M., \u201cCyclandelate in the treatment of patients with mild to moderate primary degenerative dementia of the Alzheimer type or vascular dementia: experience from a placebo controlled multi-center study,\u201d Pharmacopsychiatry, vol. 33, no. 3, pp. 89\u201397, 2000, doi: 10.1055\/S-2000-7978"},{"volume-title":"J. Neural Transm. Suppl.","author":"Gutzmann H.","key":"e_1_3_2_2_28_1","unstructured":"H. Gutzmann and D. Hadler , \u201c Sustained efficacy and safety of idebenone in the treatment of Alzheimer's disease: update on a 2-year double-blind multicentre study ,\u201d J. Neural Transm. Suppl. , vol. 54 , no. 54, pp. 301\u2013310, 1998, doi: 10.1007\/978-3-7091-7508-8_30 10.1007\/978-3-7091-7508-8_30 H. Gutzmann and D. Hadler, \u201cSustained efficacy and safety of idebenone in the treatment of Alzheimer's disease: update on a 2-year double-blind multicentre study,\u201d J. Neural Transm. Suppl., vol. 54, no. 54, pp. 301\u2013310, 1998, doi: 10.1007\/978-3-7091-7508-8_30"},{"key":"e_1_3_2_2_29_1","volume-title":"Alzheimers. Dis.","volume":"58","author":"Nakamura Norimichi","unstructured":"Norimichi Nakamura , Yasumasa Ohyagi , Tomohiro Imamura , Yuki T. Yanagihara , Kyoko M. Linuma , Naoko Soejima , Hiroyuki Murai , Ryo Yamasaki and Jun-Ichi Kira , \u201c Apomorphine Therapy for Neuronal Insulin Resistance in a Mouse Model of Alzheimer's Disease,\u201d J . Alzheimers. Dis. , vol. 58 , no. 4, pp. 1151\u20131161, 2017, doi: 10.3233\/JAD-160344 10.3233\/JAD-160344 Norimichi Nakamura, Yasumasa Ohyagi, Tomohiro Imamura, Yuki T. Yanagihara, Kyoko M. Linuma, Naoko Soejima, Hiroyuki Murai, Ryo Yamasaki and Jun-Ichi Kira, \u201cApomorphine Therapy for Neuronal Insulin Resistance in a Mouse Model of Alzheimer's Disease,\u201d J. Alzheimers. Dis., vol. 58, no. 4, pp. 1151\u20131161, 2017, doi: 10.3233\/JAD-160344"},{"volume-title":"Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion - PubMed","year":"2022","key":"e_1_3_2_2_30_1","unstructured":"\u201c Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion - PubMed .\u201d https:\/\/pubmed.ncbi.nlm.nih.gov\/10669911\/ (accessed Mar. 29, 2022 ) \u201cDouble-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion - PubMed.\u201d https:\/\/pubmed.ncbi.nlm.nih.gov\/10669911\/ (accessed Mar. 29, 2022)"},{"key":"e_1_3_2_2_31_1","volume-title":"Int. J. Neuropsychopharmacol.","volume":"16","author":"Dobarro Marta","unstructured":"Marta Dobarro , Gorka Gerenu , and Maria J. Ram\u00edrez , \u201cPropranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice ,\u201d Int. J. Neuropsychopharmacol. , vol. 16 , no. 10, pp. 2245\u20132257, Nov. 2013, doi: 10.1017\/S1461145713000631. 10.1017\/S1461145713000631 Marta Dobarro, Gorka Gerenu, and Maria J. Ram\u00edrez, \u201cPropranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice,\u201d Int. J. Neuropsychopharmacol., vol. 16, no. 10, pp. 2245\u20132257, Nov. 2013, doi: 10.1017\/S1461145713000631."},{"volume-title":"Widely used NSAID treats Alzheimer's disease in mice - The Pharmaceutical Journal","year":"2022","key":"e_1_3_2_2_32_1","unstructured":"\u201c Widely used NSAID treats Alzheimer's disease in mice - The Pharmaceutical Journal .\u201d https:\/\/pharmaceutical-journal.com\/article\/news\/widely-used-nsaid-treats-alzheimers-disease-in-mice (accessed Mar. 29, 2022 ). \u201cWidely used NSAID treats Alzheimer's disease in mice - The Pharmaceutical Journal.\u201d https:\/\/pharmaceutical-journal.com\/article\/news\/widely-used-nsaid-treats-alzheimers-disease-in-mice (accessed Mar. 29, 2022)."},{"volume-title":"Effect of buflomedil on behaviour, memory, and intellectual capacity in patients with dementia. A placebo-controlled study - PubMed","year":"2022","key":"e_1_3_2_2_33_1","unstructured":"\u201c Effect of buflomedil on behaviour, memory, and intellectual capacity in patients with dementia. A placebo-controlled study - PubMed .\u201d https:\/\/pubmed.ncbi.nlm.nih.gov\/3898413\/ (accessed Mar. 29, 2022 ). \u201cEffect of buflomedil on behaviour, memory, and intellectual capacity in patients with dementia. A placebo-controlled study - PubMed.\u201d https:\/\/pubmed.ncbi.nlm.nih.gov\/3898413\/ (accessed Mar. 29, 2022)."},{"key":"e_1_3_2_2_34_1","first-page":"748","volume-title":"Genet. Neurol. Behav. Diet Dement.","author":"Hertzog da Silva Leme Adriana Gisele","year":"2020","unstructured":"Adriana Gisele Hertzog da Silva Leme and Barbara R. Cardoso , \u201cSelenium and Alzheimer's disease ,\u201d Genet. Neurol. Behav. Diet Dement. , pp. 739\u2013 748 , Jan. 2020 , doi: 10.1016\/B978-0-12-815868-5.00047-5. 10.1016\/B978-0-12-815868-5.00047-5 Adriana Gisele Hertzog da Silva Leme and Barbara R. Cardoso, \u201cSelenium and Alzheimer's disease,\u201d Genet. Neurol. Behav. Diet Dement., pp. 739\u2013748, Jan. 2020, doi: 10.1016\/B978-0-12-815868-5.00047-5."},{"volume-title":"Drugs Today (Barc).","author":"Anton \u00c1lvarez X.","key":"e_1_3_2_2_35_1","unstructured":"X. Anton \u00c1lvarez and Patricio Fuentes , \u201c Cerebrolysin in Alzheimer's disease ,\u201d Drugs Today (Barc). , vol. 47 , no. 7, pp. 487\u2013513, Jul. 2011, doi: 10.1358\/DOT.2011.47.7.1656496 10.1358\/DOT.2011.47.7.1656496 X. Anton \u00c1lvarez and Patricio Fuentes, \u201cCerebrolysin in Alzheimer's disease,\u201d Drugs Today (Barc)., vol. 47, no. 7, pp. 487\u2013513, Jul. 2011, doi: 10.1358\/DOT.2011.47.7.1656496"}],"event":{"name":"ICBRA 2022: 2022 9th International Conference on Bioinformatics Research and Applications","acronym":"ICBRA 2022","location":"Berlin Germany"},"container-title":["Proceedings of the 9th International Conference on Bioinformatics Research and Applications"],"original-title":[],"link":[{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3569192.3569203","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dl.acm.org\/doi\/pdf\/10.1145\/3569192.3569203","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T17:51:41Z","timestamp":1750182701000},"score":1,"resource":{"primary":{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3569192.3569203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,18]]},"references-count":35,"alternative-id":["10.1145\/3569192.3569203","10.1145\/3569192"],"URL":"https:\/\/doi.org\/10.1145\/3569192.3569203","relation":{},"subject":[],"published":{"date-parts":[[2022,9,18]]},"assertion":[{"value":"2023-01-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}